-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The performance of chemical giants at a glance
Evonik's sales in 2018 amounted to 15 billion euros, up 4% year-on-year; Adjusted EBITDA of €2.
6 billion, up 10 percent year-on-year.
The adjusted EBITDA margin was 17.
3 percent, up around 1 percentage point year-on-year, and adjusted full-year net income rose 29 percent year-on-year to a record
€1.
29 billion.
Despite political uncertainty and weak economic growth, the company expects adjusted EBITDA to be flat or slightly lower than 2018 levels
in 2019.
In the fourth quarter of 2018, AkzoNobel increased adjusted operating income by €3 million to €181 million
due to pricing initiatives and cost-saving initiatives.
For the full year 2018, AkzoNobel achieved sales of €9.
256 billion, down 4% year-on-year; Adjusted operating income of €798 million, down 12% year-on-year; Adjusted EBITDA was €1,037 million, down 12 percent
year-on-year.
Covestro's full-year 2018 revenue was €14,615 million, up 3.
4 percent year-on-year; Operating profit for the full year amounted to 2.
58 billion euros, down 8.
1% year-on-year; Net profit amounted to EUR 1,823 million, down 9.
3%
year-on-year.
Sales growth in 2019 is expected to remain in the low to mid-single digits, but earnings expectations will decline and EBITDA will decline 53 percent
amid increased competition.
Clariant achieved sales of CHF 6,623 million in 2018, up 5 percent year-on-year, thanks to a positive contribution from all business areas, especially Care Chemicals, Catalysts and Plastics & Coatings.
EBIT increased by 5 percent to CHF 1,018 million; Net profit increased by 18 percent to CHF 356 million; EBITDA margin before exceptional items increased to 15.
4 percent from 15.
3 percent
in the previous year.
Solvay Driven by prices, sales grew organically by 4.
3% in the fourth quarter of 2018; Core EBITDA amounted to €506 million, with an organic increase of 3.
6 percent
.
Sales and core EBITDA grew
organically by 5.
7 percent and 5.
3 percent, respectively, in 2018, driven by higher volumes and strong net prices in all segments.
Core EBITDA amounted to €2.
23 billion and the EBITDA margin remained at 22 percent
.
Relative to the strong performance of 2018, EBITDA growth in 2019 is expected to be modest
.
In 2018, Arkema generated sales of €8.
8 billion, up 5.
9% year-on-year; EBITDA of €1,474 million, up 6 percent year-on-year; The EBITDA margin was 16.
7% and the EBIT margin was 11.
6%.
In 2019, Arkema aims to generate EBITDA at a level comparable to the record level in 2018, while driving momentum throughout the year with growth in the specialty products business
.
Arkema will continue to launch its industrial projects, strengthen its position in the specialty products business and high-growth regions, advance its acquisition program in the adhesives sector, optimize its operational excellence approach and implement a policy of
selectively increasing selling prices.
ExxonMobil's fourth-quarter 2018 revenue was $71.
89 billion, up about 8.
1% year-over-year; Net profit was US$6 billion, down 28.
4%
year-on-year.
Total revenue in 2018 reached US$290.
211 billion, a year-on-year increase of 7.
7%; Profit reached $20.
8 billion, up 6%
year-over-year.
The company expects earnings to grow by more than $4 billion
from 2019 to 2020.
PPG's net sales from continuing operations for the fourth quarter of 2018 decreased 1% to approximately $3.
6 billion.
Net income from continuing operations increased 73%
to US$256 million.
Net sales from continuing operations for the full year 2018 were approximately $15.
4 billion, up approximately 4% year-over-year.
The annual net income was US$1.
341 billion, down 15.
87% year-on-year; Net income from continuing operations for the full year was $1.
3 billion, down 7.
1%
year-over-year.
Sherwin-Williams Due to Valspar sales growth in the first five months of 2018, increased coatings sales at Group Americas and higher selling prices, Sherwin-Williams' consolidated net sales for the full year 2018 increased by 17.
0% year-over-year to $17.
53 billion, and net income for 2018 was $1.
108 billion, down 37.
4%
year-over-year.